Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, ...

Update: Citius Pharmaceuticals announced Aug. 5, 2024, that TenX Keane Acquisition’s shareholders approved their previously announced merger, which is expected to close “in the coming weeks.” Read ...

Citius Pharmaceuticals has been making big preparations as it gears up for the commercialization of its two late-stage products, including realigning its management team. On May 25, the Cranford-based ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The capital includes a $25m term loan and a warrant exercise agreement expected to yield $11.5m.

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is one of the stocks that should double in 3 years. On February 13, Citius Pharmaceuticals officially transitioned into a revenue-generating company following ...

This press release and the interview to which it relates may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities ...

Company reports $3.9 million in revenue generated from initial sales in December 2025 and provides first fiscal quarter 2026 financial results CRANFORD, N.J., Feb. 13, 2026 /PRNewswire/ -- Citius ...

Citius Pharmaceuticals, Inc. CTXR announced that it has acquired the exclusive in-license rights of Dr. Reddy’s Laboratories RDY for E7777 (denileukin diftitox). The candidate is an improved ...

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Executive Chairman Leonard Mazur told Benzinga CEO Jason Raznick Thursday that he's invested $26.5 million of his own money in the specialty pharmaceutical ...

Throughout most of June, Citius Pharmaceuticals stock climbed in anticipation of the third planned interim analysis of a phase 3 trial with Mino-Lok. This is an antibiotic lock solution that could be ...